USANA Health Sciences (USNA) reported Q1 adjusted earnings late Tuesday of $0.73 per diluted share, down from $0.86 a year earlier.
A single analyst polled by FactSet expected $0.70.
Net sales for the quarter ended March 29 were $249.5 million, up from $227.8 million a year earlier.
A lone analyst surveyed by FactSet expected $243 million.
The company reiterated its full-year 2025 adjusted diluted EPS outlook of $2.35 to $3 and net sales guidance of $920 million to $1 billion. A single analyst polled by FactSet expects adjusted diluted EPS of $2.59 and net sales of $941.6 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.